Central nervous system remyelination clinical application of basic neuroscience principles

Brain Pathology

Volumn 6, Issue 3, 1996, Pages 331-344

  Miller, David J ^a   Asakura, Kuni ^a   Rodriguez, Moses ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; IMMUNOGLOBULIN;

ANIMAL MODEL; ANIMAL TISSUE; CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; CONTROLLED STUDY; ELECTRON MICROSCOPY; GLIA CELL; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; MULTIPLE SCLEROSIS; MYELINATION; NONHUMAN;

EID: 0030037331     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1996.tb00859.x     Document Type: Conference Paper

References (101)

1. Armstrong R, Friedrich VL Jr, Holmes KV, Dubois-Dalcq M (1990) In vitro analysis of the oligodendrocyte lineage in mice during demyelination and remyelination. J Cell Biol 111: 1183-1195
2. Asakura K, Miller DJ, Murray K, Pfeiffer SE, Rodriguez M (1996) Monoclonal autoantibody SCH94.03, which promotes CNS remyelination, recognizes an antigen on the surface of oligodendrocytes J Neurosci Res 43: 273-281
3. Avrameas S, Ternynck T (1993) The natural autoantibody system between hypotheses and facts Mol Immunol 30: 1133-1142
4. Bansal R, Gard AL, Pfeiffer SE (1988) Stimulation of oligodendrocyte differentiation in culture by growth in the presence of a monoclonal antibody to sulfated glycolipid J Neurosci Res 21 260-267
5. Barnes D, Munro PMG, Youl BD, Prineas JW, McDonald WI (1991) The longstanding MS lesion a quantitative MRI and electron microscopic study. Brain 114: 1271-1280
6. Blakemore WF (1973) Demyelination in the superior cerebellar peduncle in the mouse induced by Cuprizone. J Neurol Sci 20: 63-72
7. Blakemore WF (1973) Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding Cuprizone. J Neurol Sci 20: 73-83
8. Blakemore WF (1992) Transplanted type-1 astrocytes can be used to reconstitute the glial limitans of the CNS: the structure which prevents Schwann cells from myelinating CNS axons. Neuropathol Appl Neurobiol 18: 460-466
9. Blakemore WF, Crang AJ (1989) The relationship between type-1 astrocytes, Schwann cells and oligodendrocytes following transplantation of glial cell cultures into demyelinating lesions in the adult rat spinal cord. J Neurocytol 18: 519-528
10. Blakemore WF, Crang AJ, Franklin RJM, Tang K, Ryder S (1995) Glial cell transplants that are subsequently rejected can be used to influence regeneration of glial cell environments in the CNS Glia 13 79-91
11. Blakemore WF, Franklin RJM (1991) Transplantation of glial cells into the CNS Trends Neurosci 14 323-327
12. Blakemore WF, Welsh CJR, Tonks P, Nash AA (1988) Observations on demyelinating lesions induced by Theiler's virus in CBA mice. Acta Neuropathol 76: 581-589
13. Bouldin TW, Earnhardt TS, Goines ND (1991) Restoration of blood-nerve barrier in neuropathy is associated with axonal regeneration and remyelination. J Neuropathol Exp Neurol 50 719-728
14. Brill MH, Waxman SG, Moore JW, Joyner RW (1977) Conduction velocity and spike configuration in myelinated fibers computed dependence on internode distance. J Neurol Neurosurg Psych 40 769-774
15. Cohen JA, Williams WV, Geller HM, Greene MI (1991) Anti-reovirus receptor antibody accelerates expression of the optic nerve oligodendrocyte developmental program. Proc Natl Acad Sci 88 1266-1270
16. Cook SD, Rohowsky-Kochan C, Bansil S, Dowling PC (1995) Evidence for multiple sclerosis as an infectious disease. Acta Neurol Scand 161 34-42
17. Crang AJ, Blakemore WF (1991) Remyelination of demyelinated rat axons by transplanted mouse oligodendrocytes Glia 4 305-313
18. Crang AJ, Franklin RJM, Blakemore WF, Nobel M, Barnett SC, Groves A, Trotter J, Schachner M (1992) The differentiation of glial progenitor populations following transplantation into non-repairing central nervous system glial lesions in adult animals. J Neuroimmunol 40: 243-253
19. Dal Canto MC, Barbano RL (1984) Remyelination during remission in Theiler's virus infection. Am J Pathol 116: 30-45
20. Dal Canto MC, Lipton HL (1979) Recurrent demyelination in chronic central nervous system infection produced by Theiler's murine encephalomyelitis virus J Neurol Sci 42: 391-405
21. Driscoll BF, Kies MW, Alvord EC (1974) Successful treatment of experimental allergic encephalomyelitis (EAE) in guinea pigs with homologous myelin basic protein J Immunol 112: 392-397
22. Duncan ID, Paino C, Archer DR, Wood PM (1992) Functional capacities of transplanted cell-sorted adult oligodendrocytes Dev Neurosci 14: 114-122
23. 2+ responses in oligodendrocytes J Neurosci Res 30: 699-711
24. Erlich SS, Fleming JO (1985) JHM virus infection: a model of viral-induced demyelinating disease. In The Pathology of the Myelinated Axon, Adachi M, Hirano A, Aronson SM (eds), pp. 276-307, Igaku-Shoin: New York
25. Fazakerley JK, Buchmeier MJ (1993) Pathogenesis of virus-induced demyelination. Adv Virus Res 42: 249-324
26. Felts PA, Smith KJ (1992) Conduction properties of central nerve fibers remyelinated by Schwann cells. Brain Res 574: 178-192
27. Felts PA, Smith KJ, Tilt E (1991) Blood-brain barrier function in central demyelinating lesions repaired by Schwann cell remyelination. Ann NY Acad Sci 633: 615-616
28. 2-microglobulin-deficient mice. J Virol 67: 589-592
29. Franklin RJM, Bayley SA, Milner R, Ffrench-Constant C, Blakemore WF (1995) Differentiation of the O-2A progenitor cell line CG-4 into oligodendrocytes and astrocytes following transplantation into glia-deficient areas of CNS white matter. Glia 13 39-44
30. Franklin RJM, Crang AJ, Blakemore WF (1991) Transplanted type-1 astroctyes facilitate repair of demyelinating lesions by host oligodendrocytes in adult rat spinal cord. J Neurocytol 20: 420-430
31. Gilson J, Blakemore WF (1993) Failure of remyelination in areas of demyelination produced in the spinal cord of old rats. Neuropathol Appl Neurobiol 19: 173-181
32. Godfraind C, Friedrich VL, Homes KV, Dubois-Dalcq M (1989) In vivo analysis of glial cell phenotypes during a viral demyelinating disease in mice. J Cell Biol 109: 2405-2416
33. Goldberg MA, Bunn HF (1994) Molecular and cellular hematopoiesis. In Harrison's Principles of Internal Medicine, Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL (eds.), pp. 1714-1717, McGraw-Hill: New York
34. Groves AK, Barnett SC, Franklin RJ, Crang AJ, Mayer M, Blakemore WF, Noble M (1993) Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells Nature 362: 453-455
35. Hall SM (1972) The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord J Cell Sci 13: 257-277
36. Herndon RM, Price DL, Weiner LP (1977) Regeneration of oligodendroglia during recovery from demyelinating disease. Science 195: 693-694
37. Hunter SF, Bottenstein JE (1989) Bipotential glial progenitors are targets of neuronal cell line-derived growth factors. Dev Brain Res 49: 33-49
38. Johnson ES, Ludwin SK (1981) The demonstration of recurrent demyelination and remyelination of axons in the central nervous system. Acta Neuropathol 53 93-98
39. Jordan CA, Friedrich VL Jr, de Ferra F, Weismiller DG, Holmes KV, Dubois-Dalcq M (1990) Differential exon expression in myelin basic protein transcripts during central nervous system (CNS) remyelination. Cell Mol Neurobionl 10: 3-18
40. Jordan CA, Friedrich VL Jr, Godfraind C, Cardellechio CB, Holmes KV, Dubois-Dalcq M (1989) Expression of viral and myelin gene transcripts in a murine CNS demyelinating disease caused by a coronavirus. Glia 2: 318-329
41. Kahn MA, deVellis J (1995) Growth factors in the CNS and their effects on oligodendroglia. Prog Brain Res 105: 145-169
42. Koles ZJ, Rasminsky M (1972) A computer simulation of conduction in demyelinated nerve fibers. J Physiol 227:351-364
43. Komoly S, Hudson LD, Webster HD, Bondy DA (1992) Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination. Proc Natl Acad Sci 89: 1894-1898
44. Lampert PW, Sims JK, Kniazeff AJ (1973) Mechanism of demyelination in JHM encephalomyelitis. Acta Neuropathol 24: 76-85
45. Lang W, Rodriguez M, Lennon VA, Lampert PW (1984) Demyelination and remyelination in murine viral encephalomyelitis. Ann NY Acad Sci 436: 98-102
46. Lehrer GM, Maker S, Silides DJ, Weiss C, Bornstein MB (1979) Stimulation of myelin lipid synthesis in vitro by white matter antiserum in the absence of complement. Brain Res 172: 557-560
47. Liu X, Yao DL, Bondy CA, Brenner M, Hudson LD, Zhou J, Webster HD (1994) Astrocytes express insulin-like growth factor-I (IGF-I) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune encephalomyelitis. Mol Cell Neurosci 5: 418-430
48. Ludwin SK (1980) Chronic demyelination inhibits remyelination in the central nervous system, an analysis of contributing factors. Lab Invest 43: 382-387
49. Ludwin SK (1988) Remyelination in the central nervous system and the peripheral nervous system. Adv Neurol 47 215-254
50. Ludwin SK, Maitland M (1984) Long-term remyelination fails to reconstitute normal thickness of central myelin sheaths. J Neurol Sci 64: 193-198
51. Ludwin SK, Sternberger NH (1984) An immunohistochemical study of myelin basic protein during remyelination in the central nervous system. Acta Neuropathol 63: 240-248
52. Martin R, McFarland HF, McFarlin DE (1992) Immunological aspects of demyelinating diseases. Annu Rev Immunol 10 153-187
53. McKinnon RD, Matsui T, Dubois-Dalcq M, Aaronson SA (1990) FGF modulates the PDGF-driven pathway of oligodendrocyte development Neuron 5 603-614
54. McMorris FA, Mozell RL, Carson MJ, Shinar Y, Meyer RD, Marchetti N (1993) Regulation of oligodendrocyte development and central nervous system myelination by insulin like growth factors. Ann NY Acad Sci 692: 321-334
55. Miller DJ, Njenga MK, Murray PD, Leibowitz J, Rodriguez M (1996) A monoclonal natural autoantibody that promotes remyelination suppresses central nervous system inflammation and increases virus expression after Theiler's virus-induced demyelination. Int Immunol 8: 131-141
56. 2 microglobulin-deficient mice after virus-induced demyelination. J Neurosci 15: 8345-8352
57. Miller DJ, Rodriguez M (1995) A monoclonal autoantibody that promotes central nervous system remyelination in a model of multiple sclerosis is a natural autoantibody encoded by germline immunoglobulin genes. J Immunol 154: 2460-2469
58. Miller DJ, Rodriguez M (1996) Spontaneous central nervous system remyelination in strain A mice after infection with the Daniel's (DA) strain of Theiler's virus. Acta Neuropathol, in press.
59. Miller DJ, Sanborn KS, Katzmann JA, Rodriguez M (1994) Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis. J Neurosci 14: 6230-6238
60. Newcombe J, Hawkins CP, Henderson CL, Patel HA, Woodroofe MN, Hayes GM, Cuzner ML, MacManus D, du Boulay EPGH, McDonald WI (1991) Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue. Brain 114: 1013-1023
61. Ozawa K, Suchanek G, Breitschopf H. Bruck W, Budka H, Jellinger K, Lassmann H (1994) Patterns of oligodendroglia pathology in multiple sclerosis. Brain 117: 1311-1322
62. Ozden S, Aubert C, Bureau JF, Gonzales-Dunia D, Brahic M (1993) Analysis of proteolipid protein and P0 transcripts in mice infected with Theiler's virus. Microb Pathogen 14: 123-131
63. Pfeiffer SE, Warrington AE, Bansal R (1993) The oligodendrocyte and its many cellular processes. Trends Cell Biol 3: 191-197
64. Prineas JW (1985) The neuropathology of multiple sclerosis. In Handbook of Clinical Neurology, Vol 3: Demyelinating Diseases, Koltsier JC (ed.), pp. 213-257, Elsevier: Amsterdam
65. Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho ES (1993) Multiple sclerosis: remyelination of nascent lesions Ann Neurol 33: 137-151
66. Prineas JW, Barnard RO, Revesz T, Kwon EE, Sharer LR, Cho, ES (1993) Multiple sclerosis. Pathology of recurrent lesions. Brain 116 681-693
67. Prineas JW, Kwon EE, Goldenberg PZ, Cho ES, Sharer LR (1990) Interaction of astrocyte and newly formed oligodendrocytes in resolving multiple sclerosis lesions. Lab Invest 63: 624-636
68. Prineas JW, Kwon EE, Goldenberg PZ, Ilayas AA, Quarles RH, Benjamins JA, Sprinkle TJ (1989) Multiple sclerosis: oligodendrocyte proliferation and differentiation in fresh lesions. Lab Invest 61: 489-503
69. Raff MC, Lillien LE, Richardson WD, Burne JF, Noble MD (1988) Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 333: 562-565
70. Raine CS, Mokhtarian F, McFarlin DE (1984) Adoptively transferred chronic relapsing experimental autoimmune encephalomyelitis in the mouse: neuropathological analysis Lab Invest 51 534-546
71. Raine CS, Moore GRW, Hintzen R, Traugott U (1988) Induction of oligodendrocyte proliferation and remyelination after chronic demyelination: relevance to multiple sclerosis. Lab Invest 59 467-476
72. Raine CS, Scheinberg LC, Waltz JM (1981) Multiple sclerosis oligodendrocyte survival and proliferation in an active, established lesion. Lab Invest 45: 534-546
73. Raine CS, Traugott U (1985) Remyelination in chronic relapsing experimental allergic encephalomyelitis and multiple sclerosis. In The Pathology of the Myelinated Axon, Adachi M, Hirano A, Aronson SM (eds.). pp. 229-275, Igaku-Shoin: New York
74. Raine CS, Traugott U, Stone SH (1978) Chronic relapsing experimental allergic encephalomyelitis: CNS plaque development in unsuppressed and suppressed animals. Acta Neuropathol 43: 43-53
75. Raine CS, Wu E (1993) Multiple sclerosis: remyelination in acute lesions. J Neuropathol Exp Neurol 52: 199-204
76. Reynolds R, Wilkin GP (1993) Cellular reaction to an acute demyelinating/remyelinating lesion of the rat brain stem: localisation of GD3 ganglioside immunoreactivity. J Neurosci Res 36: 405-422
77. 2-microglobulin. J Immunol 151: 266-276
78. Rodriguez M, Lennon VA (1990) Immunoglobulins promote remyelination in the central nervous system. Ann Neurol 27: 12-17
79. Rodriguez M, Lennon VA, Benveniste EN, Merrill JE (1987) Remyelination by oligodendrocytes stimulated by antiserum to spinal cord. J Neuropathol Exp Neurol 46: 84-95
80. Rodriguez M, Lindsley MD (1992) Immunosuppression promotes CNS remyelination in chronic virus-induced demyelinating disease Neurology 42: 348-357
81. Rodriguez M, Miller DJ, Lennon VA (1996) Immunoglobulins reactive with myelin basic protein promote CNS remyelination. Neurology 46: 538-545
82. Rodriguez M, Oleszak E, Leibowitz J (1987) Theiler's murine encephalomyelitis a model of demyelination and persistence of virus CRC Cut Rev Immunol 7 325-365
83. Rodriguez M, Scheithauer B (1994) Ultrastructure of multiple sclerosis Ultrastruct Pathol 18 3-13
84. Segal BM, Raine CS, McFarlin DE, Voskuhl RR, McFarland HF (1994) Experimental allergic encephalomyelitis induced by the peptide encoded by exon 2 of the MBP gene, a peptide implicated in remyelination. J Neuroimmunol 51: 7-19
85. Smith KJ, Blakemore WF, McDonald WI (1979) Central remyelination restores secure conduction. Nature 280: 395-396
86. Smith KJ, Hall SM (1980) Nerve conduction during peripheral demyelination and remyelination. J Neurol Sci 48:201-219
87. Stanley GP, Pender MP (1991) The pathophysiology of chronic relapsing experimental allergic encephalomyelitis in the Lewis rat Brain 114: 1827-1853
88. Steinman L (1991) The development of rational strategies for selective immunotherapy against autoimmune demyelinating diseases Adv Immunol 49: 357-379
89. Stohlman SA, Weiner LP (1981) Chronic central nervous system demyelination in mice after JHM virus infection. Neurology 31: 38-44
90. Traugott U, Stone SH, Raine CS (1982) Chronic relapsing experimental autoimmune encephalomyelitis: treatment with combinations of myelin components promotes clinical and structural improvement. J Neurol Sci 56: 65-73
91. Utzschneider DA, Archer DR, Kocsis JD, Waxman SG, Duncan ID (1994) Transplantation of glial cells enhances action potential conduction of amyelinated spinal cord axons in the myelin deficient rat. Proc Natl Acad Sci 91:53-57
92. Voskuhl RR, McFarlin DE, Stone R, McFarland HF (1993) T-lymphocyte recognition of a portion of myelin basic protein encoded by an exon expressed during myelination. J Neuroimmunol 42 187-191
93. Wang FI, Stohlman SA, Fleming JO (1990) Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated J Neuroimmunol 30: 31-41
94. Waxman SG (1988) Clinical course and electrophysiology of multiple sclerosis. Adv Neurol 47: 157-184
95. Waxman SG, Kocsis JD, Black JA (1995) Pathophysiology of demyelinated axons. In The Axon Structure, Function, and Pathophysiology, Waxman SG, Kocsis JD, Stys PK (eds.), pp. 438-461, Oxford University Press: Oxford, New York
96. Weiner HL, Friedman A, Miller A, Khoury SJ, Al-Subbagh A, Santos L, Sayegh M, Nussenblatt RB, Trentham DE, Hafler DA (1994) Oral tolerance: immunological mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 12: 890-837
97. Whitaker JN (1994) Rationale for immunotherapy in multiple sclerosis. Ann Neurol 36: S103-S107
98. Wolburg H (1981) Myelination and remyelination in the regenerating visual system of the goldfish. Exp Brain Res 43 199-206
99. Yajima K, Suzuki K (1979) Demyelination and remyelination in the rat central nervous system following ethidium bromide injection. Lab Invest 41: 385-392
100. Yamada M, Zurbriggen A, Fujinami RS (1991) Pathogenesis of Theiler's murine encephalomyelitis virus. Adv Virus Res 39: 291-320
101. Youl BD, Turano G, Miller DH, Towell AD, MacManus D, Moore SG, Jones SJ, Barrett G, Kendall BE, Moseley IF, Tofts PS, Halliday AM, McDonald WI (1991) The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits Brain 114: 2437-2450